Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE NORTH AMERICA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.1.1 POLITICAL FACTORS
4.1.2 ECONOMIC FACTORS
4.1.3 SOCIAL FACTORS
4.1.4 TECHNOLOGICAL FACTORS
4.1.5 LEGAL FACTORS
4.1.6 ENVIRONMENTAL FACTORS
4.2 PORTER’S FIVE FORCES
4.2.1 THREAT OF NEW ENTRANTS
4.2.2 BARGAINING POWER OF SUPPLIERS
4.2.3 BARGAINING POWER OF BUYERS
4.2.4 THREAT OF SUBSTITUTES
4.2.5 COMPETITIVE RIVALRY
4.3 INNOVATION STRATEGIES
4.3.1 KEY INNOVATION STRATEGIES
4.3.2 EMERGING DELIVERY TECHNIQUES
4.3.3 STRATEGIC IMPLICATIONS
4.3.4 CONCLUSION
4.4 INNOVATION STRATEGIES
4.4.1 KEY INNOVATION STRATEGIES
4.4.2 EMERGING DELIVERY TECHNIQUES
4.4.3 STRATEGIC IMPLICATIONS
4.4.4 CONCLUSION
4.5 SUPPLY CHAIN ANALYSIS
4.5.1 OVERVIEW
4.5.2 RAW MATERIAL AVAILABILITY
4.5.3 MANUFACTURING CAPACITY
4.5.4 LOGISTICS AND LAST-MILE HURDLES
4.5.5 PRICING MODELS AND MARKET POSITIONING
4.6 RISK AND MITIGATION
4.7 VENDOR SELECTION DYNAMICS
4.7.1 PRODUCT QUALITY AND REGULATORY EXCELLENCE
4.7.2 PLASMA SUPPLY SECURITY AND SUPPLY CHAIN RESILIENCE
4.7.3 CLINICAL PERFORMANCE, INDICATION BREADTH, AND INNOVATION
4.7.4 COST STRUCTURE, CONTRACT FLEXIBILITY, AND REIMBURSEMENT ALIGNMENT
4.7.5 GEOGRAPHIC FOOTPRINT AND LOCAL MARKET SUPPORT
4.7.6 ETHICAL PLASMA SOURCING, ESG COMMITMENTS, AND TRANSPARENCY
4.7.7 STRATEGIC PARTNERSHIPS AND LONG-TERM VALUE CREATION
4.7.8 CONCLUSION
5 TARIFFS & IMPACT ON THE MARKET
5.1 CURRENT TARIFF RATES IN TOP-5 COUNTRY MARKETS
5.2 OUTLOOK: LOCAL PRODUCTION VS. IMPORT RELIANCE
5.3 VENDOR SELECTION CRITERIA DYNAMICS
5.4 IMPACT ON SUPPLY CHAIN
5.4.1 PLASMA COLLECTION & RAW MATERIAL AVAILABILITY
5.4.2 MANUFACTURING AND FRACTIONATION
5.4.3 LOGISTICS AND DISTRIBUTION
5.4.4 PRICING AND MARKET POSITIONING
5.5 INDUSTRY PARTICIPANTS: PROACTIVE MOVES
5.5.1 SUPPLY CHAIN OPTIMIZATION
5.5.2 STRATEGIC PARTNERSHIPS & JOINT VENTURES
5.6 IMPACT ON PRICES
5.7 REGULATORY INCLINATION
5.7.1 GCC TRADE ALIGNMENT & FTAS
5.7.2 SPECIAL ZONES AND RE-EXPORT MODELS
5.7.3 LOCAL SUBSIDY & POLICY RESPONSE
5.7.4 DOMESTIC COURSE OF CORRECTION
6 REGULATION COVERAGE
7 MARKET OVERVIEW
7.1 DRIVER
7.1.1 RISING PREVALENCE OF RARE AND CHRONIC DISEASES
7.1.2 EXPANDING GERIATRIC POPULATION
7.1.3 TECHNOLOGICAL ADVANCEMENTS IN PLASMA FRACTIONATION
7.1.4 GOVERNMENT AND INSTITUTIONAL SUPPORT
7.2 RESTRAINTS
7.2.1 HIGH COST AND COMPLEX MANUFACTURING PROCESS
7.2.2 LACK OF PLASMA SUPPLY AND DONOR
7.3 OPPORTUNITIES
7.3.1 ADVANCEMENTS IN PLASMA PROCESSING TECHNOLOGIES TO ENHANCE YIELD AND REDUCE COSTS
7.3.2 REIMBURSEMENT FRAMEWORKS AND INCREASED GOVERNMENTAL FOCUS ON RARE DISEASE TREATMENT
7.3.3 STRATEGIC ALLIANCES, MERGERS, AND ACQUISITIONS TO STRENGTHEN NORTH AMERICA MARKET PENETRATION
7.4 CHALLENGES
7.4.1 COMPETITIVE PRESSURE FROM RECOMBINANT AND ALTERNATIVE BIOLOGICAL THERAPIES
7.4.2 INFRASTRUCTURE LIMITATIONS IN COLD CHAIN LOGISTICS IMPACTING PRODUCT DISTRIBUTION
8 NORTH AMERICA BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 IMMUNOGLOBULINS
8.3 COAGULATION FACTORS
8.4 ALBUMIN
8.5 PROTEASE INHIBITORS
8.6 MONOCLONAL ANTIBODIES
8.7 OTHER PLASMA DERIVED PROTEINS
8.8 NORTH AMERICA IMMUNOGLOBULINS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
8.8.1 NORTH AMERICA
8.8.2 EUROPE
8.8.3 ASIA-PACIFIC
8.8.4 SOUTH AMERICA
8.8.5 MIDDLE EAST AND AFRICA
8.9 NORTH AMERICA COAGULATION FACTORS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
8.9.1 NORTH AMERICA
8.9.2 EUROPE
8.9.3 ASIA-PACIFIC
8.9.4 SOUTH AMERICA
8.9.5 MIDDLE EAST AND AFRICA
8.1 NORTH AMERICA ALBUMIN IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
8.10.1 NORTH AMERICA
8.10.2 EUROPE
8.10.3 ASIA-PACIFIC
8.10.4 SOUTH AMERICA
8.10.5 MIDDLE EAST AND AFRICA
8.11 NORTH AMERICA PROTEASE INHIBITORS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
8.11.1 NORTH AMERICA
8.11.2 EUROPE
8.11.3 ASIA-PACIFIC
8.11.4 SOUTH AMERICA
8.11.5 MIDDLE EAST AND AFRICA
8.12 NORTH AMERICA MONOCLONAL ANTIBODIES IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
8.12.1 NORTH AMERICA
8.12.2 EUROPE
8.12.3 ASIA-PACIFIC
8.12.4 SOUTH AMERICA
8.12.5 MIDDLE EAST AND AFRICA
8.13 NORTH AMERICA OTHER PLASMA DERIVED PROTEINS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
8.13.1 NORTH AMERICA
8.13.2 EUROPE
8.13.3 ASIA-PACIFIC
8.13.4 SOUTH AMERICA
8.13.5 MIDDLE EAST AND AFRICA
9 NORTH AMERICA BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 IMMUNOLOGY
9.3 HAEMATOLOGY
9.4 CRITICAL CARE
9.5 NEUROLOGY
9.6 PULMONOLOGY
9.7 HAEMATO-ONCOLOGY
9.8 RHEUMATOLOGY
9.9 OTHER APPLICATIONS
9.1 NORTH AMERICA IMMUNOLOGY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.10.1 NORTH AMERICA
9.10.2 EUROPE
9.10.3 ASIA-PACIFIC
9.10.4 SOUTH AMERICA
9.10.5 MIDDLE EAST AND AFRICA
9.11 NORTH AMERICA HAEMATOLOGY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.11.1 NORTH AMERICA
9.11.2 EUROPE
9.11.3 ASIA-PACIFIC
9.11.4 SOUTH AMERICA
9.11.5 MIDDLE EAST AND AFRICA
9.12 NORTH AMERICA CRITICAL CARE IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.12.1 NORTH AMERICA
9.12.2 EUROPE
9.12.3 ASIA-PACIFIC
9.12.4 SOUTH AMERICA
9.12.5 MIDDLE EAST AND AFRICA
9.13 NORTH AMERICA NEUROLOGY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.13.1 NORTH AMERICA
9.13.2 EUROPE
9.13.3 ASIA-PACIFIC
9.13.4 SOUTH AMERICA
9.13.5 MIDDLE EAST AND AFRICA
9.14 NORTH AMERICA PULMONOLOGY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.14.1 NORTH AMERICA
9.14.2 EUROPE
9.14.3 ASIA-PACIFIC
9.14.4 SOUTH AMERICA
9.14.5 MIDDLE EAST AND AFRICA
9.15 NORTH AMERICA HAEMATO-ONCOLOGY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.15.1 NORTH AMERICA
9.15.2 EUROPE
9.15.3 ASIA-PACIFIC
9.15.4 SOUTH AMERICA
9.15.5 MIDDLE EAST AND AFRICA
9.16 NORTH AMERICA RHEUMATOLOGY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.16.1 NORTH AMERICA
9.16.2 EUROPE
9.16.3 ASIA-PACIFIC
9.16.4 SOUTH AMERICA
9.16.5 MIDDLE EAST AND AFRICA
9.17 NORTH AMERICA OTHER APPLICATIONS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.17.1 NORTH AMERICA
9.17.2 EUROPE
9.17.3 ASIA-PACIFIC
9.17.4 SOUTH AMERICA
9.17.5 MIDDLE EAST AND AFRICA
10 NORTH AMERICA BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY
10.1 OVERVIEW
10.2 ION EXCHANGE CHROMATOGRAPHY
10.3 AFFINITY CHROMATOGRAPHY
10.4 CRYOPRECIPITATION
10.5 ULTRAFILTRATION
10.6 MICROFILTRATION
10.7 NORTH AMERICA ION EXCHANGE CHROMATOGRAPHY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
10.7.1 NORTH AMERICA
10.7.2 EUROPE
10.7.3 ASIA-PACIFIC
10.7.4 SOUTH AMERICA
10.7.5 MIDDLE EAST AND AFRICA
10.8 NORTH AMERICA AFFINITY CHROMATOGRAPHY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
10.8.1 NORTH AMERICA
10.8.2 EUROPE
10.8.3 ASIA-PACIFIC
10.8.4 SOUTH AMERICA
10.8.5 MIDDLE EAST AND AFRICA
10.9 NORTH AMERICA CRYOPRECIPITATION IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
10.9.1 NORTH AMERICA
10.9.2 EUROPE
10.9.3 ASIA-PACIFIC
10.9.4 SOUTH AMERICA
10.9.5 MIDDLE EAST AND AFRICA
10.1 NORTH AMERICA ULTRAFILTRATION IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
10.10.1 NORTH AMERICA
10.10.2 EUROPE
10.10.3 ASIA-PACIFIC
10.10.4 SOUTH AMERICA
10.10.5 MIDDLE EAST AND AFRICA
10.11 NORTH AMERICA MICROFILTRATION IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
10.11.1 NORTH AMERICA
10.11.2 EUROPE
10.11.3 ASIA-PACIFIC
10.11.4 SOUTH AMERICA
10.11.5 MIDDLE EAST AND AFRICA
11 NORTH AMERICA BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE
11.1 OVERVIEW
11.2 MODERN
11.3 TRADITIONAL PLASMA FRACTIONATION
11.4 NORTH AMERICA MODERN IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
11.4.1 NORTH AMERICA
11.4.2 EUROPE
11.4.3 ASIA-PACIFIC
11.4.4 SOUTH AMERICA
11.4.5 MIDDLE EAST AND AFRICA
11.5 NORTH AMERICA TRADITIONAL PLASMA FRACTIONATION IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
11.5.1 NORTH AMERICA
11.5.2 EUROPE
11.5.3 ASIA-PACIFIC
11.5.4 SOUTH AMERICA
11.5.5 MIDDLE EAST AND AFRICA
12 NORTH AMERICA BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS & CLINICS
12.3 RESEARCH LABS
12.4 ACADEMIC INSTITUTES
12.5 OTHERS
12.6 NORTH AMERICA HOSPITALS & CLINICS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
12.6.1 NORTH AMERICA
12.6.2 EUROPE
12.6.3 ASIA-PACIFIC
12.6.4 SOUTH AMERICA
12.6.5 MIDDLE EAST AND AFRICA
12.7 NORTH AMERICA RESEARCH LABS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
12.7.1 NORTH AMERICA
12.7.2 EUROPE
12.7.3 ASIA-PACIFIC
12.7.4 SOUTH AMERICA
12.7.5 MIDDLE EAST AND AFRICA
12.8 NORTH AMERICA ACADEMIC INSTITUTES IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
12.8.1 NORTH AMERICA
12.8.2 EUROPE
12.8.3 ASIA-PACIFIC
12.8.4 SOUTH AMERICA
12.8.5 MIDDLE EAST AND AFRICA
12.9 NORTH AMERICA OTHERS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
12.9.1 NORTH AMERICA
12.9.2 EUROPE
12.9.3 ASIA-PACIFIC
12.9.4 SOUTH AMERICA
12.9.5 MIDDLE EAST AND AFRICA
13 NORTH AMERICA BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDERS
13.3 THIRD PARTY DISTRIBUTORS
13.4 OTHERS
13.5 NORTH AMERICA DIRECT TENDERS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
13.5.1 NORTH AMERICA
13.5.2 EUROPE
13.5.3 ASIA-PACIFIC
13.5.4 SOUTH AMERICA
13.5.5 MIDDLE EAST AND AFRICA
13.6 NORTH AMERICA THIRD PARTY DISTRIBUTORS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
13.6.1 NORTH AMERICA
13.6.2 EUROPE
13.6.3 ASIA-PACIFIC
13.6.4 SOUTH AMERICA
13.6.5 MIDDLE EAST AND AFRICA
13.7 NORTH AMERICA OTHERS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
13.7.1 NORTH AMERICA
13.7.2 EUROPE
13.7.3 ASIA-PACIFIC
13.7.4 SOUTH AMERICA
13.7.5 MIDDLE EAST AND AFRICA
14 NORTH AMERICA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION
14.1 NORTH AMERICA
14.1.1 U.S.
14.1.2 CANADA
14.1.3 MEXICO
15 NORTH AMERICA BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: GLOBAL
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 CSL
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 COMPANY SHARE ANALYSIS
17.1.4 PRODUCT PORTFOLIO
17.1.5 RECENT DEVELOPMENT
17.2 TAKEDA PHARMACEUTICAL COMPANY LIMITED
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 COMPANY SHARE ANALYSIS
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENT
17.3 GRIFOLS, S.A.
17.3.1 COMPANY SNAPSHOT
17.3.2 REVENUE ANALYSIS
17.3.3 COMPANY SHARE ANALYSIS
17.3.4 PRODUCT PORTFOLIO
17.3.5 RECENT DEVELOPMENT
17.4 OCTAPHARMA AG
17.4.1 COMPANY SNAPSHOT
17.4.2 COMPANY SHARE ANALYSIS
17.4.3 PRODUCT PORTFOLIO
17.4.4 RECENT DEVELOPMENT
17.5 KEDRION
17.5.1 COMPANY SNAPSHOT
17.5.2 COMPANY SHARE ANALYSIS
17.5.3 PRODUCT PORTFOLIO
17.5.4 RECENT DEVELOPMENT
17.6 ADMA BIOLOGICS, INC
17.6.1 COMPANY SNAPSHOT
17.6.2 REVENUE ANALYSIS
17.6.3 PRODUCT PORTFOLIO
17.6.4 RECENT DEVELOPMENT
17.7 AEGROS
17.7.1 COMPANY SNAPSHOT
17.7.2 PRODUCT PORTFOLIO
17.7.3 RECENT DEVELOPMENT
17.8 BHARAT SERUMS
17.8.1 COMPANY SNAPSHOT
17.8.2 PRODUCT PORTFOLIO
17.8.3 RECENT DEVELOPMENT
17.9 BIOTEST AG.
17.9.1 COMPANY SNAPSHOT
17.9.2 REVENUE ANALYSIS
17.9.3 PRODUCT PORTFOLIO
17.9.4 RECENT DEVELOPMENT
17.1 FRESENIUS KABI AG
17.10.1 COMPANY SNAPSHOT
17.10.2 PRODUCT PORTFOLIO
17.10.3 RECENT DEVELOPMENT
17.11 GC BIOPHARMA CORPORATE
17.11.1 COMPANY SNAPSHOT
17.11.2 REVENUE ANALYSIS
17.11.3 PRODUCT PORTFOLIO
17.11.4 RECENT DEVELOPMENT
17.12 ICHOR
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENT
17.13 INTAS PHARMACEUTICALS LTD.
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENT
17.14 KAMADA PHARMACEUTICALS
17.14.1 COMPANY SNAPSHOT
17.14.2 REVENUE ANALYSIS
17.14.3 PRODUCT PORTFOLIO
17.14.4 RECENT DEVELOPMENT
17.15 KM BIOLOGICS
17.15.1 COMPANY SNAPSHOT
17.15.2 PRODUCT PORTFOLIO
17.15.3 RECENT DEVELOPMENT
17.16 LFB
17.16.1 COMPANY SNAPSHOT
17.16.2 THERAPY PORTFOLIO
17.16.3 RECENT DEVELOPMENT
17.17 PLASMAGEN BIOSCIENCES PVT. LTD.
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENT
17.18 PROLIANT HEALTH & BIOLOGICALS
17.18.1 COMPANY SNAPSHOT
17.18.2 PRODUCT PORTFOLIO
17.18.3 RECENT DEVELOPMENT
17.19 PROMEA
17.19.1 COMPANY SNAPSHOT
17.19.2 PRODUCT PORTFOLIO
17.19.3 RECENT DEVELOPMENT
17.2 RELIANCE LIFE SCIENCES.
17.20.1 COMPANY SNAPSHOT
17.20.2 PRODUCT PORTFOLIO
17.20.3 RECENT DEVELOPMENT
17.21 SICHUAN YUANDA SHYUANG PHARMACEUTICAL CO., LTD.
17.21.1 COMPANY SNAPSHOT
17.21.2 PRODUCT PORTFOLIO
17.21.3 RECENT DEVELOPMENT
17.22 SK PLASMA
17.22.1 COMPANY SNAPSHOT
17.22.2 PRODUCT PORTFOLIO
17.22.3 RECENT DEVELOPMENT
17.23 SYNTHAVERSE S. A.
17.23.1 COMPANY SNAPSHOT
17.23.2 REVENUE ANALYSIS
17.23.3 PRODUCT PORTFOLIO
17.23.4 RECENT DEVELOPMENT
17.24 TAIBANG BIO GROUP CO., LTD
17.24.1 COMPANY SNAPSHOT
17.24.2 PRODUCT PORTFOLIO
17.24.3 RECENT DEVELOPMENT
17.25 VIRCHOW BIOTECH
17.25.1 COMPANY SNAPSHOT
17.25.2 PRODUCT PORTFOLIO
17.25.3 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
List of Table
TABLE 1 NORTH AMERICA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 2 NORTH AMERICA IMMUNOGLOBULINS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 3 NORTH AMERICA COAGULATION FACTORS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 4 NORTH AMERICA ALBUMIN IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 5 NORTH AMERICA PROTEASE INHIBITORS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 6 NORTH AMERICA MONOCLONAL ANTIBODIES IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 7 NORTH AMERICA OTHER PLASMA DERIVED PROTEINS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 8 NORTH AMERICA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 9 NORTH AMERICA IMMUNOLOGY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 10 NORTH AMERICA HAEMATOLOGY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 11 NORTH AMERICA CRITICAL CARE IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 12 NORTH AMERICA NEUROLOGY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 13 NORTH AMERICA PULMONOLOGY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 14 NORTH AMERICA HAEMATO-ONCOLOGY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 15 NORTH AMERICA RHEUMATOLOGY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 16 NORTH AMERICA OTHER APPLICATIONS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 17 NORTH AMERICA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 18 NORTH AMERICA ION EXCHANGE CHROMATOGRAPHY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 19 NORTH AMERICA AFFINITY CHROMATOGRAPHY IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 20 NORTH AMERICA CRYOPRECIPITATION IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 21 NORTH AMERICA ULTRAFILTRATION IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 22 NORTH AMERICA MICROFILTRATION IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 23 NORTH AMERICA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 24 NORTH AMERICA MODERN IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 25 NORTH AMERICA TRADITIONAL PLASMA FRACTIONATION IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 26 NORTH AMERICA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 27 NORTH AMERICA HOSPITALS & CLINICS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 28 NORTH AMERICA RESEARCH LABS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 29 NORTH AMERICA ACADEMIC INSTITUTES IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 30 NORTH AMERICA OTHERS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 31 NORTH AMERICA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 32 NORTH AMERICA DIRECT TENDERS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 33 NORTH AMERICA THIRD PARTY DISTRIBUTORS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 34 NORTH AMERICA OTHERS IN BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 35 NORTH AMERICA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY COUNTRY, 2018-2033 (USD THOUSAND)
TABLE 36 NORTH AMERICA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 37 NORTH AMERICA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 38 NORTH AMERICA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 39 NORTH AMERICA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 40 NORTH AMERICA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 41 NORTH AMERICA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 42 U.S. BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 43 U.S. BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 44 U.S. BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 45 U.S. BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 46 U.S. BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 47 U.S. BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 48 CANADA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 49 CANADA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 50 CANADA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 51 CANADA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 52 CANADA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 53 CANADA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 54 MEXICO BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 55 MEXICO BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 56 MEXICO BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY TECHNOLOGY, 2018-2033 (USD THOUSAND)
TABLE 57 MEXICO BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY MODE, 2018-2033 (USD THOUSAND)
TABLE 58 MEXICO BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 59 MEXICO BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
List of Figure
FIGURE 1 NORTH AMERICA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 NORTH AMERICA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 NORTH AMERICA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET: SEGMENTATION
FIGURE 11 NORTH AMERICA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET: EXECUTIVE SUMMARY
FIGURE 12 STRATEGIC DECISIONS
FIGURE 13 NORTH AMEIRCA IS EXPECTED TO DOMINATE THE MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE NORTH AMERICA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET IN THE FORECAST PERIOD OF 2025 TO 2032
FIGURE 14 NORTH AMERICA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, BY PRODUCT (2024)
FIGURE 15 RISING PREVELANCE OF RARE & CHRONIC DISEASES IS EXPECTED TO DRIVE THE NORTH AMERICA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET, IN THE FORECAST PERIOD OF 2026 TO 2033
FIGURE 16 IMMUNOGLOBULINS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET IN THE FORECAST PERIOD OF 2026 & 2033
FIGURE 17 ASIA-PACIFIC IS THE FASTEST-GROWING REGION FOR NORTH AMERICA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET IN THE FORECAST PERIOD OF 2026 TO 2033
FIGURE 18 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES FOR THE NORTH AMERICA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET
FIGURE 19 NORTH AMERICA BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY PRODUCT, 2025
FIGURE 20 NORTH AMERICA BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY PRODUCT, 2026 TO 2033 (USD THOUSAND)
FIGURE 21 NORTH AMERICA BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY PRODUCT, CAGR (2026- 2033)
FIGURE 22 NORTH AMERICA BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 23 NORTH AMERICA BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY APPLICATION, 2025
FIGURE 24 NORTH AMERICA BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY APPLICATION, 2026 TO 2033 (USD THOUSAND)
FIGURE 25 NORTH AMERICA BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY APPLICATION, CAGR (2026- 2033)
FIGURE 26 NORTH AMERICA BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 27 NORTH AMERICA BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY TECHNOLOGY, 2025
FIGURE 28 NORTH AMERICA BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY TECHNOLOGY, 2026 TO 2033 (USD THOUSAND)
FIGURE 29 NORTH AMERICA BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY TECHNOLOGY, CAGR (2026- 2033)
FIGURE 30 NORTH AMERICA BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 31 NORTH AMERICA BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY MODE, 2025
FIGURE 32 NORTH AMERICA BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY MODE, 2026 TO 2033 (USD THOUSAND)
FIGURE 33 NORTH AMERICA BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY MODE, CAGR (2026- 2033)
FIGURE 34 NORTH AMERICA BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY MODE, LIFELINE CURVE
FIGURE 35 NORTH AMERICA BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY END USER, 2025
FIGURE 36 NORTH AMERICA BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY END USER, 2026 TO 2033 (USD THOUSAND)
FIGURE 37 NORTH AMERICA BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY END USER, CAGR (2026- 2033)
FIGURE 38 NORTH AMERICA BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY END USER, LIFELINE CURVE
FIGURE 39 NORTH AMERICA BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, 2025
FIGURE 40 NORTH AMERICA BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, 2026 TO 2033 (USD THOUSAND)
FIGURE 41 NORTH AMERICA BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2026- 2033)
FIGURE 42 NORTH AMERICA BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 43 NORTH AMERICA BLOOD PLASMA & PLASMA DERIVED MEDICINAL PRODUCTS MARKET: SNAPSHOT (2025)
FIGURE 44 NORTH AMERICA BLOOD PLASMA AND PLASMA DERIVED MEDICINAL PRODUCTS MARKET: COMPANY SHARE 2025 (%)
